Das Unternehmen meldete in den letzten zwölf Monaten 171 Millionen mit einem Nettoumsatzwachstum von 60 % und seinem besten EBITDA aller Zeiten SÃO PAULO, 22. Mai 2023 /PRNewswire/ — Die Oncoclínicas Group (ONCO3), die größte Gruppe, die sich in Lateinamerika der Krebsbehandlung widmet, gab ihre Ergebnisse für das erste Quartal 2023 bekannt, mit einem Wachstum von 33 % zum … Read more
The company reported 171 million for the last twelve months, with a 60% growth in net revenue and its best EBITDA ever SÃO PAULO, May 21, 2023 /PRNewswire/ – Oncoclínicas Group (ONCO3) – the largest group dedicated to cancer treatment in Latin America – announced its results for the first quarter of 2023, marking its … Read more
The company reported 171 million for the last twelve months, with a 60% growth in net revenue and its best EBITDA ever SÃO PAULO, May 21, 2023 /PRNewswire/ – Oncoclínicas Group (ONCO3) – the largest group dedicated to cancer treatment in Latin America – announced its results for the first quarter of 2023, marking its … Read more